Takasago, Japan

Naofumi Shiomi

This inventor holds 1 USPTO granted patent. Top assignee: Kanegafuchi Kagaku Kogyo Kabushiki Kaisha. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naofumi Shiomi. Retrieved from https://idiyas.com/inventor/naofumi-shiomi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naofumi Shiomi: Innovator in Gene Technology

Introduction

Naofumi Shiomi is a prominent inventor based in Takasago, Japan. He has made significant contributions to the field of gene technology, particularly in enhancing the accumulation of S-adenosyl-L-methionine (SAM). His work has implications for therapeutic applications, making it a noteworthy area of study.

Latest Patents

Naofumi Shiomi holds a patent for a gene capable of enhancing S-adenosyl-L-methionine accumulation. This invention includes a gene that provides resistance to at least one methionine derivative and is capable of enhancing the accumulation of SAM in a cell. The patent also covers a hybrid plasmid containing this gene, a cell transformed with the hybrid plasmid, and a process for producing SAM using the transformed cell. This innovation allows for the large-scale production of SAM at a low cost, which has various therapeutic effects.

Career Highlights

Shiomi is associated with Kanegafuchi Kagaku Kogyo Kabushiki Kaisha, where he continues to advance his research in gene technology. His work has been instrumental in developing methods that can potentially revolutionize therapeutic production processes.

Collaborations

Naofumi Shiomi collaborates with Hideki Fukuda, contributing to the advancement of their shared research interests in gene technology.

Conclusion

Naofumi Shiomi's innovative work in gene technology, particularly his patent on enhancing S-adenosyl-L-methionine accumulation, showcases his significant contributions to the field. His efforts in collaboration with others further enhance the potential impact of his research on therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…